AstraZeneca
AZN
$76.41
Share price
0.70%
Change (1 day)
3.96%
Change (1 year)
Categories
AstraZeneca (AZN) - Total debt
Total debt on the balance sheet as of March 2024 : $34.55 B
According to AstraZeneca's latest financial reports the company's total debt is $34.55 B. A company’s total debt is the sum of all current and non-current debts.
AstraZeneca - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $28.62 B | -2.09% |
| 2022-12-31 | $29.23 B | -5.03% |
| 2021-12-31 | $30.78 B | 51.04% |
| 2020-12-31 | $20.38 B | 11.81% |
| 2019-12-31 | $18.22 B | -4.64% |
| 2018-12-31 | $19.11 B | 7.33% |
| 2017-12-31 | $17.80 B | 5.94% |
| 2016-12-31 | $16.80 B | 11.66% |
| 2015-12-31 | $15.05 B | 38.83% |
| 2014-12-31 | $10.84 B | 4.5% |
| 2013-12-31 | $10.37 B | 0.64% |
| 2012-12-31 | $10.31 B | 10.53% |
| 2011-12-31 | $9.32 B | 1.15% |
| 2010-12-31 | $9.22 B | -16.64% |
| 2009-12-31 | $11.06 B | 868.74% |
| 2008-12-31 | $1.14 B | -92.47% |
| 2007-12-31 | $15.15 B | 1139.25% |
| 2006-12-31 | $1.22 B | 1.83% |
| 2005-12-31 | $1.20 B | -5.36% |
| 2004-12-31 | $1.26 B | 178.9% |
| 2003-12-31 | $0.45 B | -46.09% |
| 2002-12-31 | $0.84 B | -11.72% |
| 2001-12-31 | $0.95 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | -15.11% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | -21.03% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 105.04% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | -54.77% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | -26.99% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | -41.05% | 🇫🇷 France |
 Biogen BIIB | $6.94 B | -79.89% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 1.46% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 66.16% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | -33.61% | 🇬🇧 UK |